NCT04504942 2026-01-23Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsCytoDyn, Inc.Phase 2 Completed16 enrolled 16 charts
NCT05435339 2025-04-22A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as MonotherapyGenmabPhase 1/2 Terminated31 enrolled 29 charts